Mullerian Inhibiting Substance is an ovarian growth factor of emerging clinical significance
- 7 June 2007
- journal article
- review article
- Published by Elsevier BV in Fertility and Sterility
- Vol. 88 (3), 539-546
- https://doi.org/10.1016/j.fertnstert.2007.02.014
Abstract
No abstract availableKeywords
This publication has 58 references indexed in Scilit:
- Early follicular antimüllerian hormone as an indicator of ovarian reserveFertility and Sterility, 2006
- Müllerian-inhibiting substance reflects ovarian findings in women with polycystic ovary syndrome better than does inhibin BFertility and Sterility, 2005
- Serum müllerian-inhibiting substance levels in adolescent girls with normal menstrual cycles or with polycystic ovary syndromeFertility and Sterility, 2005
- Anti‐müllerian hormone as a marker of ovarian reserve*Australian and New Zealand Journal of Obstetrics and Gynaecology, 2005
- Metformin reduces serum müllerian-inhibiting substance levels in women with polycystic ovary syndrome after protracted treatmentFertility and Sterility, 2005
- Serum antimüllerian hormone/müllerian-inhibiting substance appears to be a more discriminatory marker of assisted reproductive technology outcome than follicle-stimulating hormone, inhibin B, or estradiolFertility and Sterility, 2004
- Steroidogenic activities in MA-10 Leydig cells are differentially altered by cAMP and Müllerian inhibiting substanceThe Journal of Steroid Biochemistry and Molecular Biology, 2004
- Serum müllerian-inhibiting substance levels during normal menstrual cyclesFertility and Sterility, 2000
- Mapping of the gene for anti-Müllerian hormone to the short arm of human chromosome 19Cytogenetic and Genome Research, 1987
- The Production of Mullerian Inhibiting Substance by the Fetal, Neonatal and Adult Rat1Biology of Reproduction, 1976